Intestinal glucose metabolism revisited

Diabetes Research and Clinical Practice

Volumn 105, Issue 3, 2014, Pages 295-301

  Mithieux, Gilles ^a,b,c   Gautier Stein, Amandine ^a,b,c  

^a INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Intestinal glucose metabolism

Indexed keywords

CYCLIC AMP; FFAR3 PROTEIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE 6 PHOSPHATASE; GLUCOSE TRANSPORTER 2; GLUTAMINASE; PHLORIZIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (PYROPHOSPHATE); PROPIONIC ACID; SODIUM GLUCOSE COTRANSPORTER; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2; SODIUM GLUCOSE COTRANSPORTER 3; UNCLASSIFIED DRUG; GLUCOSE; PROTEIN INTAKE;

ANTIDIABETIC ACTIVITY; DIET RESTRICTION; DIETARY FIBER; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HUMAN; INTESTINAL GLUCOSE METABOLISM; INTESTINE FLORA; INTESTINE FUNCTION; METABOLIC PARAMETERS; METABOLIC REGULATION; NONHUMAN; OBESITY; PORTAL GLUCOSE SENSING; PORTAL VEIN; PROTEIN FUNCTION; PROTEIN INTAKE; REVIEW; SATIETY; STOMACH BYPASS; ANIMAL; DIABETES MELLITUS; HOMEOSTASIS; HUNGER; INTESTINE; LIVER; METABOLISM; MOUSE; PHYSIOLOGY; RAT;

ANIMALS; DIABETES MELLITUS; DIETARY FIBER; DIETARY PROTEINS; FASTING; GASTRIC BYPASS; GLUCONEOGENESIS; GLUCOSE; GLUCOSE-6-PHOSPHATASE; HOMEOSTASIS; HUMANS; HUNGER; INTESTINES; LIVER; MICE; OBESITY; RATS;

EID: 84921634582     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.04.008     Document Type: Review

References (58)

1. Little T.J., Feinle-Bisset C. Effects of dietary fat on appetite and energy intake in health and obesity-oral and gastrointestinal sensory contributions. Physiol Behav 2011, 104:613-620.
2. Janssen P., Van Den Berghe P., Verschueren S., Lehmann A., Depoortere I., Tack J. Review article: the role of gastric motility in the control of food intake. Aliment Pharmacol Ther 2011, 33:880-894.
3. Date Y., Murakami N., Toshinai K., Matsukura S., Niijima A., Matsuo H., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
4. Smith G.P., Jerome C., Cushin B.J., Eterno R., Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981, 213:1036-1037.
5. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 2005, 1044:127-131.
6. Vahl T.P., Tauchi M., Durler T.S., Elfers E.E., Fernandes T.M., Bitner R.D., et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 148:4965-4973.
7. Breen D., Yang C.S., Lam T.K. Gut-brain signaling: how lipids can trigger the gut. Diabetes Metab Res Rev 2011, 27:113-119.
8. Tordoff M.G., Schulkin, Friedman M.I. Hepatic portal glucose infusions decrease food intake and increase food preference. Am J Physiol 1986, 251:R192-R196.
9. Langhans W., Grossmann F., Geary N. Intrameal hepatic-portal infusion of glucose reduces spontaneous meal size in rats. Physiol Behav 2001, 73:499-507.
10. Delaere F., Magnan C., Mithieux G. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab 2010, 36:257-262.
11. Mithieux G., Misery P., Magnan C., Pillot B., Gautier-Stein A., Bernard C., et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab 2005, 2:321-329.
12. Baird J.P., Grill H.J., Kaplan J.M. Intake suppression after hepatic portal glucose infusion: all-or-none effect and its temporal threshold. Am J Physiol 1997, 272:R1454-R1460.
13. Delaere F., Duchampt A., Mounien L., Seyer P., Duraffourd C., Zitoun C., et al. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol Metab 2012, 2:47-53.
14. Berthoud H.R. Anatomy and function of sensory hepatic nerves. Anat Rec A: Discov Mol Cell Evol Biol 2004, 280:827-835.
15. Krebs H.A. Some aspects of the regulation of fuel supply in omnivorous animals. Adv Enzym Regul 1972, 10:397-420.
16. Bailey C.J., Mynett K.J., Page T. Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol 1994, 112:671-675.
17. Mithieux G., Rajas R., Zitoun C. Glucose utilization is suppressed in the gut of insulin resistant high-fat fed rats and is restored by metformin. Biochem Pharmacol 2006, 72:198-203.
18. Windmueller H.G., Spaeth A.E. Uptake and metabolism of plasma glutamine by the small intestine. J Biol Chem 1974, 249:5070-5079.
19. Windmueller H.G., Spaeth A.E. Identification of ketone bodies and glutamine as the major respiratory fuels in vivo for postabsorptive rat small intestine. J Biol Chem 1978, 253:69-76.
20. Rajas F., Bruni N., Montano S., Zitoun C., Mithieux G. The glucose-6 phosphatase gene is expressed in human and rat small intestine: regulation of expression in fasted and diabetic rats. Gastroenterology 1999, 117:132-139.
21. Croset M., Rajas F., Zitoun C., Hurot J.M., Montano S., Mithieux G. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes 2001, 50:740-746.
22. Mithieux G., Bady I., Gautier A., Croset M., Rajas F., Zitoun C. Induction of control genes in intestinal gluconeogenesis is sequential during fasting and maximal in diabetes. Am J Physiol Endocrinol Metab 2004, 286:E370-E375.
23. Rajas F., Croset M., Zitoun C., Montano S., Mithieux G. Induction of PEPCK gene expression in insulinopenia in rat small intestine. Diabetes 2000, 49:1165-1168.
24. Mithieux G., Vidal H., Zitoun C., Bruni N., Daniele N., Minassian C. Glucose-6 phosphatase mRNA and activity are increased to the same extent in kidney and liver of diabetic rats. Diabetes 1996, 45:891-896.
25. Minassian C., Mithieux G. Differential time course of liver and kidney glucose-6 phosphatase activity during fasting in rats. Comp Biochem Physiol 1994, 109B:99-104.
26. Minassian C., Zitoun C., Mithieux G. Differential time-course of liver and kidney glucose-6 phosphatase activity during long-term fasting in rat correlates with differential time-course of messenger RNA level. Mol Cell Biochem 1996, 155:37-41.
27. Mithieux G., Daniele N., Payrastre B., Zitoun C. Liver microsomal glucose-6 phosphatase is competitively inhibited by the lipid products of phosphatidyl-inositol 3-kinase. J Biol Chem 1998, 273:17-19.
28. Daniele N., Rajas F., Payrastre B., Mauco G., Zitoun C., Mithieux G. Phosphatidylinositol 3-kinase translocates onto liver endoplasmic reticulum and may account for the inhibition of glucose-6 phosphatase during refeeding. J Biol Chem 1999, 274:3597-3601.
29. Mithieux G., Vega F.V., Riou J.P. The liver glucose-6-phosphatase of intact microsomes is inhibited and displays sigmoid kinetics in the presence of α-keto glutarate-magnesium and oxalo-acetate-magnesium chelates. J Biol Chem 1990, 265:20364-20368.
30. Mithieux G., Zitoun C. Mechanisms by which fatty acyl-CoA esters inhibit or activate glucose-6 phosphatase in intact and detergent-treated rat liver microsomes. Eur J Biochem 1996, 235:799-803.
31. Mithieux G., Rajas F., Gautier-Stein A. A novel role for glucose 6 phosphatase in the small intestine in the control of glucose homeostasis. J Biol Chem 2004, 279:44231-44423.
32. Pillot B., Duraffourd C., Bégeot M., Joly A., Luquet S., Houberdon I., et al. Role of hypothalamic melanocortin system in adaptation of food intake to food protein increase in mice. PLoS ONE 2011, 6:e71910.
33. Penhoat A., Mutel E., Amigo-Correig M., Pillot B., Stefanutti A., Rajas F., et al. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol Behav 2011, 105:89-93.
34. Berridge K.C. 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol Behav 2009, 97:537-550.
35. Zioudrou C., Streaty R.A., Klee W.A. Opioid peptides derived from food proteins. The exorphins. J Biol Chem 1979, 254:1449-2446.
36. Capasso A., Amodeo P., Balboni G., Guerrini R., Lazarus L.H., Temussi P.A., et al. Design of mu selective opioid dipeptide antagonists. FEBS Lett 1997, 417:141-144.
37. Moritoki H., Takei M., Kotani M., Kiso Y., Ishida Y., Endoh K. Tripeptides acting on opioid receptors in rat colon. Eur J Pharmacol 1984, 100:29-39.
38. Schiller P. Opioid dipeptide derivatives with a mixed μ antagonist/δantagonist, partial μ agonist/δ antagonist or μ agonist/partialδ agonist profile. Am Pept Symp 2002, 6:229-270.
39. Lee V.H. Membrane transporters. Eur J Pharmacol Sci 2000, 2(Suppl.):S41-S50.
40. Holzer P. Opioid receptors in the gastrointestinal tract. Regul Pept 2009, 155:11-17.
41. Duraffourd C., De Vadder F., Goncalves D., Delaere F., Penhoat A., Brusset B., et al. Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell 2012, 150:377-438.
42. Flint H.J., Scott K.P., Louis P., Duncan S.H. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012, 9:577-589.
43. Ray T.K., Mansell K.M., Knight L.C., Malmud L.S., Owen O.E., Boden G. Long-term effects of dietary fiber on glucose tolerance and gastric emptying in noninsulin-dependent diabetic patients. Am J Clin Nutr 1983, 37:376-381.
44. Mendeloff A.I. Dietary fiber and human health. N Engl J Med 1977, 297:811-814.
45. Donohoe D.R., Garge N., Zhang X., Sun W., O'Connell T.M., Bunger M.K., et al. The microbiome and butyrate regulate energy metabolism and autophagy in the Mammalian colon. Cell Metab 2011, 13:517-526.
46. Anderson J.W., Bridges S.R. Short-chain fatty acid fermentation products of plant fiber affect glucose metabolism of isolated rat hepatocytes. Proc Soc Exp Biol Med 1984, 177:372-376.
47. Clore J.N., Stillman J., Sugerman H. Glucose-6-phosphatase flux in vitro is increased in type 2 diabetes. Diabetes 2000, 49:969-974.
48. Magnusson I., Rothman D.L., Katz L.D., Shulman R.G., Shulman G.I. Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. J Clin Invest 1992, 90:1323-1327.
49. De Vadder F., Kovatcheva-Datchary P., Goncalves D., Vinera J., Zitoun C., Duchampt A., et al. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell 2014, 156:84-96.
50. Gautier-Stein A., Zitoun C., Lalli E., Mithieux G., Rajas F. Transcriptional regulation of the glucose-6-phosphatase gene by cAMP/vasoactive intestinal peptide in the intestine. Role of HNF4alpha, CREM, HNF1alpha, and C/EBPalpha. J Biol Chem 2006, 281:31268-31278.
51. Thaler J.P., Cummings D.E. Minireview: hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009, 150:2518-2525.
52. Sala P.C., Torrinhas R.S., Heymsfield S.B., Waitzberg D.L. Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction. Obes Surg 2012, 22:167-176.
53. Perez-Tilve D., D'Alessio D.A., Tschop M.H. A sweet spot for the bariatric surgeon. Cell Metab 2008, 8:177-179.
54. Troy S., Soty M., Ribeiro L., Laval L., Migrenne S., Fioramonti X., et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab 2008, 8:201-211.
55. Hayes M.T., Foo J., Besic C., Tychinskaya Y., Stubbs R.S. Is intestinal gluconeogenesis a key factor in the early changes in glucose homeostasis following gastric bypass?. Obes Surg 2011, 21:759-762.
56. Mithieux G. Comment about intestinal gluconeogenesis after gastric bypass in human in relation with the paper by Hayes et al., Obes. Surg. 2011. Obes Surg 2011, 22:1920-1922.
57. Mithieux G. A synergy between incretin effect and intestinal gluconeogenesis accounting for the rapid metabolic benefits of gastric bypass surgery. Curr Diab Rep 2012, 12:167-171.
58. Warne J.P., Xu A.W. Metabolic transceivers: in tune with the central melanocortin system. Trends Endocrinol Metab 2013, 24:68-75.